Home » Newsletters » BioWorld

BioWorld

April 7, 1994

View Archived Issues

IDUN LICENSES BCL-X GENE

ANERGEN'S MYASTHENIA GRAVIS PROGRAM MOVES FORWARD

DIAGNON PLANS CANCER-FOCUSED CORPORATION

ONCOGENE GETS BROAD PATENT

SMITHKLINE LICENSES CORLOPAM RIGHTS TO NEUREX

GERMANY, ITALY BAR SALESOF DDI DRUG

IMCLONE GETS CRC CANCER VACCINE RIGHTS

METASYN COMPLETES $4M PRIVATE PLACEMENT

TOP CLOT BUSTER GRADUATES FROM HEART TO LIMBS TO BRAIN

NEW THERAPY IMPROVES GENE EXPRESSION

ANGRY SHAREHOLDERS PROPOSE CHANGES AT SCIOS NOVA

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026